FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:1316-1317 April 30, 1998 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Connolly, H. M. PubMed Citation

To the Editor: It has been previously reported that valvular heart disease may be associated with the use of anorectic drugs.¹ We report a case of restrictive cardiomyopathy due to endocardial fibrosis after short-term use of fenfluramine–phentermine.

A 35-year-old woman was hospitalized for congestive heart failure. Five months earlier she had begun taking 10 mg of fenfluramine three times a day and 15 mg of phentermine once a day, prescribed at her request because of obesity (height, 1.77 m; weight, 94.5 kg; body-mass index [calculated as the weight in kilograms divided by the square of the height in meters], 30.3). . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Droogmans, S., Kerkhove, D., Cosyns, B., Van Camp, G. (2009). Role of echocardiography in toxic heart valvulopathy. Eur J Echocardiogr 10: 467-476 [Abstract] [Full Text]